Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2003
03/13/2003WO2003020721A1 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases
03/13/2003WO2003020719A1 1,3-benzothiazinone derivatives and use thereof
03/13/2003WO2003020716A1 Piperidine derivatives useful as ccr5 antagonists
03/13/2003WO2003020715A1 Aminopyrrole compounds as antiinflammatory agents
03/13/2003WO2003020712A1 Oxadiazolyl-phenoxyalkylthiadiazoles, compositions thereof and methods for their use as anti-picornaviral agents
03/13/2003WO2003020711A1 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin
03/13/2003WO2003020710A1 Benzothiazepine derivatives
03/13/2003WO2003020707A1 Optical isomers of an iloperidone metabolite
03/13/2003WO2003020706A1 PROCESS FOR THE PREPARATION OF CYCLOPENTA[g]QUINAZOLINE DERIVATIVES
03/13/2003WO2003020705A1 Urea and thiourea derivatives as non-nucleoside reverse transcriptase inhibitors
03/13/2003WO2003020703A1 Cyclic amine compound
03/13/2003WO2003020701A2 Multi-use multimodal imaging chelates
03/13/2003WO2003020700A2 SUBSTITUTED INDENO[1,2-c]ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF
03/13/2003WO2003020698A2 Protein tyrosine kinase inhibitors
03/13/2003WO2003020697A1 C2-disubstituted indane-1-ones and their derivatives, method for their production and their use as medicaments
03/13/2003WO2003020696A1 C2-substituted indane-1-ols and their derivatives, method for their production and their use as medicaments
03/13/2003WO2003020695A1 C2-disubstituted indane-1-ol systems, method for their production and their use as medicaments
03/13/2003WO2003020694A1 Derivatives of c2-substituted indan-1-ol systems, methods for the production thereof and their use as medicaments
03/13/2003WO2003020693A1 Polysubstituted indan-1-ol systems, method for the production and use thereof as drugs
03/13/2003WO2003020690A1 Aryl sulfamate derivatives
03/13/2003WO2003020677A2 C2-substituted indane-1-ones and their derivatives, method for their production and their use as medicaments
03/13/2003WO2003020371A2 Potentiator composition comprising a terpene for enhancing a therapeutical effect of antitumoral agents in the treatment of cancer
03/13/2003WO2003020370A1 Method for treating alzheimer's disease using quinaldoyl-amine derivatives of oxo- and hydroxy-substituted hydrocarbons
03/13/2003WO2003020329A1 Hormone-coated stent for preventing stenosis or atherosclerosis
03/13/2003WO2003020315A1 Medicinal compositions containing angiotensin ii receptor antagonist
03/13/2003WO2003020314A1 Compositions for the treatment of parkinson's disease containing a cb1 receptor antagonist and a product that activates dopaminergic neurotransmission in the brain
03/13/2003WO2003020313A1 Remedies for respiratory diseases comprising sphingosine-1-phosphate receptor controller
03/13/2003WO2003020312A1 Remedy for ischemic heart failure
03/13/2003WO2003020311A1 Remedies for skin diseases
03/13/2003WO2003020310A1 Preventives and/or remedies for diseases caused by endosteal microcirculatory disorders
03/13/2003WO2003020309A2 Compound
03/13/2003WO2003020300A1 Use of cyclopenta[g]quinazoline derivatives for treating cancer
03/13/2003WO2003020298A1 Optimal compositions and methods thereof for treating hcv infections
03/13/2003WO2003020294A1 Aromatase marking
03/13/2003WO2003020292A1 A product for prolonging life only made from biological materials
03/13/2003WO2003020291A1 Increased solubility flavanolignan preparations
03/13/2003WO2003020290A1 Therapeutic process for p. aeruginosa infections using macrolide antibiotics
03/13/2003WO2003020289A1 Treatment of dementia and memory disorders with anticonvulsants and acetylcholinesterase inhibitors
03/13/2003WO2003020288A1 D-mannose contraceptives
03/13/2003WO2003020287A2 Methods for the treatment of chronic pain anc compositions therefor
03/13/2003WO2003020286A1 The diagnosis and treatment of airways disease
03/13/2003WO2003020285A1 Preparation for the treatment of female incontinence
03/13/2003WO2003020284A1 Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma
03/13/2003WO2003020283A2 Method for treating diabetic retinopathy
03/13/2003WO2003020282A1 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity
03/13/2003WO2003020281A1 Use of compounds for treating conditions resulting from injury to the corneal nerve after lasik and other ocular surgeries or trauma
03/13/2003WO2003020280A2 Compositions and use thereof in the treatment of cancer
03/13/2003WO2003020279A2 Compositions and methods of treatment of cancer
03/13/2003WO2003020278A1 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
03/13/2003WO2003020277A1 USE OF ACTIVE INGREDIENTS HAVING A ν-OPIOID RECEPTOR AGONIST ACTION AND AN OPIOID RECEPTOR ANTAGONIST ACTION, AS COMBINATION DRUGS FOR THE TREATMENT OF CANCER
03/13/2003WO2003020276A1 Tyrosine kinase inhibitors
03/13/2003WO2003020275A1 Novel piperidin-2,6-dione bisulphate salts and their use for the treatment of stress-related affective disorders
03/13/2003WO2003020274A1 Treatment of atopic dermatitis
03/13/2003WO2003020273A2 Pharmaceutical composition comprising gabapentin or an analogue thereof and an $g(a)-aminoamide and its analgesic use
03/13/2003WO2003020272A1 Compositions and methods for the treatment of cancer
03/13/2003WO2003020269A1 Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar activators
03/13/2003WO2003020268A1 Method for the treatment and prevention of cachexia
03/13/2003WO2003020267A1 Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration
03/13/2003WO2003020266A1 Antineoplastic combinations
03/13/2003WO2003020265A2 Compositions comprising pectin and ascorbic acid
03/13/2003WO2003020264A1 Remedial agent for cancer and cancer preventive
03/13/2003WO2003020263A1 Use of c2-substituted indane-1-ol systems for producing medicaments for the prophylaxis or treatment of obesity
03/13/2003WO2003020262A2 Use of polyunsaturated fatty acids for intra-arterial injection for selectively occluding blood supplies to neoplasias
03/13/2003WO2003020261A1 Pharmaceutical composition comprising lumiracoxib
03/13/2003WO2003020260A1 Arginine compositions for coordinate modification of multiple cardiovascular risk factors
03/13/2003WO2003020259A2 Combinations of dmxaa and other anti-cancer agents
03/13/2003WO2003020258A1 Anti-influenza drugs
03/13/2003WO2003020257A2 USE OF β-ADRENOCEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
03/13/2003WO2003020256A1 Use of c2-substituted indane-1-one systems for producing medicaments for the prophylaxis or treatment of obesity
03/13/2003WO2003020255A1 Use of polysubstituted indan-1-ol systems for producing drugs used in the prophylaxis or treatment of obesity
03/13/2003WO2003020254A1 Pharmaceutical composition comprising (-)-secoisolariciresinol
03/13/2003WO2003020253A2 Pharmaceutical compositions for the treatment of asthma
03/13/2003WO2003020252A2 Treatment of chronic myelogenous leukemia, resistant or intolerant to sti571, involving homoharringtonine alone or combined with other agents
03/13/2003WO2003020251A1 Method for enhancing endothelial function in humans
03/13/2003WO2003020250A1 Plaster for the treatment of dysfunctions and disorders of nail growth
03/13/2003WO2003020248A1 Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole
03/13/2003WO2003020245A1 Residual solvent extraction method and microparticles produced thereby
03/13/2003WO2003020243A1 Combination dosage form containing a cholesterol -lowering agent , an inhibitor of the renin-angiotensin, and aspirin
03/13/2003WO2003020242A1 Sustained release preparations
03/13/2003WO2003020241A2 Functional powders for oral delivery
03/13/2003WO2003020240A2 Therapeutic agent delivery tampon
03/13/2003WO2003020227A1 Compositions and methods relating to prevention of chemotherapy-induced alopecia
03/13/2003WO2003020222A2 PYRROLO[2,3-d]PYRIMIDINES FOR INHIBITING RNA-DEPENDENT RNA VIRAL POLYMERASE
03/13/2003WO2003020221A2 Method of treating cancerous disease
03/13/2003WO2003020219A2 Aerosolized decongestants for the treatment of sinusitis
03/13/2003WO2003020218A2 Salvianolic acid b
03/13/2003WO2003020217A2 Novel pyrazole analogs acting on cannabinoid receptors
03/13/2003WO2003020216A1 Methods for inhibiting cognitive deterioration in adults with down's syndrome
03/13/2003WO2003020210A2 Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy
03/13/2003WO2003020209A2 Processes for the production of alpha-difluoromethyl ornithine (dfmo)
03/13/2003WO2003020208A2 Treatment of neurologic hemorrhage
03/13/2003WO2003020206A2 Use of atazanavir in hiv therapy
03/13/2003WO2003020202A2 Method for reducing hypertension and heart failure
03/13/2003WO2003020199A1 Use of derivatives of c2-substituted indan-1-ol systems for producing medicaments for the prophylaxis or the treatment of obesity
03/13/2003WO2003020172A1 An implantable and sealable system for unidirectional delivery of therapeutic agents to targeted tissues
03/13/2003WO2003020037A1 Multivesicular emulsion topical delivery systems
03/13/2003WO2003020031A1 Use of non-toxic crosslinking reagents to improve fatigue resistance and reduce mechanical degradation of intervertebral disc and other collagenous tissues
03/13/2003WO2003020029A1 Arylamines as inhibitors of chemokine binding to us28
03/13/2003WO2003004472A8 Arylamines for the treatment of conditions associated with gsk-3
03/13/2003WO2003000225A3 Pharmaceutical formulation having a masked taste and method for the production thereof
1 ... 5534 5535 5536 5537 5538 5539 5540 5541 5542 5543 5544 5545 5546 5547 5548 5549 5550 5551 5552 5553 5554 ... 7860